Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.1 USD | -5.19% | -4.55% | -39.31% |
May. 09 | Nephros, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 09 | Transcript : Nephros, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 15.7M | Sales 2025 * | 18.05M | Capitalization | 22.14M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.41 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 * |
-32.3
x | P/E ratio 2025 * |
210
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.77% |
Latest transcript on Nephros, Inc.
1 day | -5.19% | ||
1 week | -4.55% | ||
Current month | -5.83% | ||
1 month | -0.94% | ||
3 months | -41.18% | ||
6 months | +7.14% | ||
Current year | -39.31% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Banks
CEO | Chief Executive Officer | 49 | 23-03-30 |
Judy Krandel
DFI | Director of Finance/CFO | 59 | Oct. 31 |
Alfred Vargas
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Amron
BRD | Director/Board Member | 67 | 07-09-18 |
Oliver Spandow
BRD | Director/Board Member | 52 | 18-08-09 |
Alisa Lask
BRD | Director/Board Member | 53 | 19-02-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 2.1 | -5.19% | 10,663 |
24-05-09 | 2.215 | +2.07% | 5,084 |
24-05-08 | 2.17 | -1.36% | 22,780 |
24-05-07 | 2.2 | +0.46% | 24,498 |
24-05-06 | 2.19 | -0.45% | 20,326 |
Delayed Quote Nasdaq, May 10, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.31% | 22.14M | |
+15.01% | 9.05B | |
+45.55% | 2.51B | |
-11.82% | 1.04B | |
-7.53% | 765M | |
+20.48% | 696M | |
+16.71% | 679M | |
-14.98% | 601M | |
-4.45% | 580M | |
+12.61% | 561M |
- Stock Market
- Equities
- NEPH Stock